Shiratori Pharmaceutical
About Shiratori Pharmaceutical
Certifications
-
FDA -
GMP
Categories
-
JP -
2020On CPHI since
-
2Certificates
-
100 - 249Employees
Company types
Primary activities
Contact info
-
-
-
JBSL Kanda Building 7F, 12 Kanda Higashi Matsushita, 101-0042, Chiyoda-ku, Tokyo-to, Japan
Meet us at
CPHI Japan 2025
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
09 Apr 2025 – 11 Apr 2025
CPHI Frankfurt 2025
Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025
Products from Shiratori Pharmaceutical (5)
-
Product Brexpiprazole
To be supplied to USA, EU and Japan. -
Product Cabazitaxel Acetonate
To be supplied to USA, EU and Japan. -
Product Eltrombopag Olamine
Process validation is to be carried out soon. -
Product Pemafibrate
To be supplied to USA, EU and Japan. -
Product Tafamidis
Process validation will be completed in early 2025.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance